Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 683 | 481 |
| Cost of Goods | N/A | 315 | 237 |
| Gross Profit | N/A | 368 | 244 |
| Operating Expenses | 0 | 5,083 | 4,088 |
| Operating Income | N/A | -4,400 | -3,607 |
| Other Income | 0 | 1 | 2 |
| Pre-tax Income | 0 | -4,399 | -3,604 |
| Net Income Continuous | N/A | -4,399 | -3,604 |
| Net Income | $N/A | $-4,399 | $-3,604 |
| EPS Basic Total Ops | N/A | -0.89 | -0.73 |
| EPS Basic Continuous Ops | N/A | -0.89 | -0.73 |
| EPS Diluted Total Ops | N/A | -0.89 | -0.73 |
| EPS Diluted Continuous Ops | N/A | -0.89 | -0.73 |
| EBITDA(a) | $N/A | $-4,384 | $-3,607 |